Trials / Terminated
TerminatedNCT00079911
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons With CD4+ Lymphocyte Count <100 Cells/mm3.
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical research study will be an international trial evaluating the safety and effectiveness of a marketed drug compared to placebo (like a sugar pill) for the suppression of repeated genital herpes infections in HIV-infected subjects with CD4+ count \<100 cells/mm3.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valacyclovir hydrochloride | valacyclovir hydrochloride |
Timeline
- Start date
- 2004-03-12
- Primary completion
- 2004-10-15
- Completion
- 2004-10-15
- First posted
- 2004-03-19
- Last updated
- 2020-11-24
Locations
5 sites across 3 countries: United States, Australia, Hong Kong
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00079911. Inclusion in this directory is not an endorsement.